Overweight and obesity in 7 to 10-year-old Hungarian boys. Short communication

A Prókai1, J Mészáros, Z Mészáros

  • 1Faculty of Physical Education and Sport Sciences, Semmelweis University, Alkotás u. 44, H-1123 Budapest, Hungary.

Acta Physiologica Hungarica
|September 15, 2007
PubMed

Insights

Overweight and obesity are rising health concerns in Hungarian boys aged 7-10, with prevalence increasing with age. Lifestyle changes are the primary driver, necessitating interventions in diet and physical activity.

Area of Science:

  • Pediatrics
  • Public Health
  • Human Growth and Development

Background:

  • Childhood overweight and obesity present a significant global health challenge.
  • Previous Hungarian studies lacked detailed nutritional status categorization for children.
  • A need exists to assess current trends in pediatric obesity in Hungary.

Purpose of the Study:

  • To determine the prevalence of overweight and obesity among Hungarian boys aged 7-10 years.
  • To analyze the relationship between age and nutritional status in this cohort.
  • To identify contributing factors to the observed prevalence rates.

Main Methods:

  • Cross-sectional study involving 7173 boys aged 7-10 years across Hungary (2003-2005).
  • Measurements included height, body mass, and four skinfold thicknesses.
  • Nutritional status assessed using Body Mass Index (BMI) and relative body fat percentage.

Main Results:

  • Prevalence of overweight and obesity increased significantly with age, ranging from 10.3% to 23.4%.
  • Both secular growth trends and lifestyle changes contributed, with lifestyle factors being more influential.
  • Higher prevalence correlated with increased risk of chronic childhood diseases.

Conclusions:

  • Childhood overweight and obesity rates are alarmingly high and increasing in Hungary.
  • Lifestyle modifications, including diet and physical activity, are crucial for addressing this public health issue.
  • Current school physical education programs may be insufficient to counteract these trends.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Signs of Puberty01:27

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
Anorexia Nervosa01:28

Anorexia Nervosa

Anorexia nervosa is a complex and severe eating disorder characterized by an intense fear of weight gain, an unrelenting pursuit of thinness, and a distorted body image. It often leads to dangerously low body weight relative to an individual's age and height. This disorder is marked by significant physical and psychological consequences, making it one of the most life-threatening psychiatric illnesses.
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...